This segment focuses on the research, development, manufacturing, and commercialization of products for cardiovascular interventions. R&D activities include the design and testing of coronary stents, balloons, catheters, guide wires, and accessories for PCI procedures. Technologies employed involve advanced materials science, precision engineering, and biocompatible coatings to improve device performance and safety. The therapeutic area is primarily cardiology, addressing conditions like coronary artery disease. Patient impact is significant, as these products are used to treat and prevent heart attacks and other cardiovascular events, improving patient outcomes and quality of life. Lepu Medical holds a strong market position in China and is expanding globally, with competitive advantages in product innovation and cost-effectiveness. Future opportunities include the development of next-generation stents and bioabsorbable vascular scaffolds. Regulatory and clinical aspects involve rigorous testing and approvals from regulatory bodies like the NMPA and FDA. Partnerships with hospitals and medical professionals are crucial for clinical trials and market access.

This segment is dedicated to the development and commercialization of products for treating structural heart diseases. R&D efforts concentrate on creating innovative occluders, vascular plugs, delivery systems, and mechanical heart valves. Technologies utilized include advanced materials, minimally invasive techniques, and imaging guidance to improve the precision and safety of procedures. The therapeutic area is cardiology, specifically addressing congenital heart defects and valvular heart diseases. The patient impact is substantial, offering life-saving treatments and improving the quality of life for patients with structural heart conditions. Lepu Medical aims to strengthen its market position by expanding its product portfolio and entering new markets. Future opportunities include the development of transcatheter heart valve technologies and innovative closure devices. Regulatory and clinical aspects involve stringent testing and approvals to ensure safety and efficacy. Collaborations with leading cardiologists and hospitals are essential for clinical trials and market adoption.

This segment focuses on the development, manufacturing, and distribution of in vitro diagnostic equipment and reagents. R&D activities include the development of diagnostic tests for various diseases, including cardiovascular diseases, infectious diseases, and cancer. Technologies used include immunoassay, molecular diagnostics, and point-of-care testing. The therapeutic areas covered include a wide range of diseases, enabling early detection and diagnosis. Patient impact is significant, as IVD products aid in the timely diagnosis and management of diseases, leading to improved patient outcomes. Lepu Medical aims to expand its IVD product portfolio and market reach. Future opportunities include the development of new biomarkers and companion diagnostics. Regulatory and clinical aspects involve obtaining approvals from regulatory bodies such as the NMPA and FDA. Partnerships with hospitals, laboratories, and healthcare providers are crucial for market access and clinical validation.

This segment encompasses the development, manufacturing, and marketing of surgical devices and accessories. R&D activities focus on creating innovative surgical staplers, endo surgery accessories, and other related products. Technologies employed include advanced materials, precision engineering, and ergonomic design to improve surgical efficiency and patient outcomes. The therapeutic areas covered include general surgery and minimally invasive procedures. Patient impact is significant, as these products contribute to safer and more effective surgical interventions. Lepu Medical aims to expand its surgical product portfolio and market share. Future opportunities include the development of advanced surgical robotics and smart surgical tools. Regulatory and clinical aspects involve obtaining approvals from regulatory bodies. Partnerships with surgeons and hospitals are crucial for clinical trials and market adoption.